Q-STRIP
Live / Registered — Registered — Section 8 accepted (as of 25 Apr 2025)
What this means for you
Registered since 04 Jun 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Jun 2029: the §8 & §9 renewal).
Record
- Serial number
- 88005113
- Registration number
- 5771296
- Mark type
- Word mark
- Filed
- 18 Jun 2018
- Published for opposition
- 20 Nov 2018
- Registered
- 04 Jun 2019
- Next maintenance filing
- §8 & §9 renewal, due by 04 Jun 2029 (grace period to 04 Dec 2029)
Goods and services
- Class 001 — Chemicals: Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology
- Class 010 — Medical apparatus: Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit
Owner
- CDG Biotech Corporation, Westlake Village, CA, US
- CDG Biotech Corporation, Westlake Village, CA, US
- CDG Biotech Corporation, Westlake Village, CA, US
Prosecution history
- 25 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 25 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 25 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Nov 2024 — TEAS SECTION 8 RECEIVED
- 04 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 03 May 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 May 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Apr 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Mar 2019 — USE AMENDMENT FILED
- 10 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Mar 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Mar 2019 — TEAS STATEMENT OF USE RECEIVED
- 15 Jan 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Nov 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED